|
Prestige Consumer Healthcare Inc., formerly Prestige Brands Holdings, Inc. is engaged in the marketing, sales and distribution of over-the-counter healthcare products. The Company operates through two segments: North American Over-the-Counter (OTC) Healthcare, and International Over-the-Counter Healthcare. Its portfolio of OTC healthcare products includes core brands, such as DenTek specialty oral care products, Monistat women's health products, Nix lice treatment, Chloraseptic sore throat treatments, Clear Eyes eye care products, Compound W wart treatments, The Doctor's NightGuard dental protector, Little Remedies pediatric over-the-counter products, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatment, BC and Goody's pain relievers, Beano gas prevention, Debrox earwax remover, and Gaviscon antacid.
Number of employees : 520 people.
|
|
| 2020 | USD (in Million) | % | Over-the-Counter Healthcare | 963.01 | 100% |
|
|
| 2019 | 2020 | Delta | USD (in Million) | % | USD (in Million) | % | United States | 837.05 | 85.8% | 812.65 | 84.4% | -2.91% | Rest of World | 93.67 | 9.6% | 104.01 | 10.8% | +11.03% | North America | 45.05 | 4.6% | 46.35 | 4.8% | +2.88% |
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
Stock A |
1 |
53,882,802 |
49,660,872 |
92.2% |
3,779,000 |
7.0% |
92.2% |
|
|
Name | Equities | % | The Vanguard Group, Inc. | 4,666,820 |
9.31% | Dimensional Fund Advisors LP | 3,476,168 |
6.94% | Champlain Investment Partners LLC | 2,427,480 |
4.84% | BlackRock Fund Advisors | 1,864,790 |
3.72% | ArrowMark Colorado Holdings LLC | 1,860,158 |
3.71% | Macquarie Investment Management Business Trust | 1,796,399 |
3.59% | Artisan Partners LP | 1,785,900 |
3.56% | SSgA Funds Management, Inc. | 1,719,429 |
3.43% | TIG Advisors LLC | 1,581,625 |
3.16% | Centaurus Capital Ltd. | 1,548,509 |
3.09% |
|
Company contact information |
|
| |
|
Sector Pharmaceuticals - NEC
Connections : Prestige Consumer Healthcare Inc.
|